Also found in: Wikipedia.
EUSAEdinburgh University Students' Association (Scotland)
EUSAEighth United States Army
EUSAElectrical & Utilities Safety Association (Ontario, Canada)
EUSAEuropean Union Studies Association
EUSAEnd User Software Agreement
EUSAEnd User Special Access
References in periodicals archive ?
It has orphan drug designation for neuroblastoma treatment in the US and EU, and EUSA plans to file the product for approval in the United States in 2017.
Under the terms of the agreement, EUSA Pharma will pay Apeiron an upfront fee, with a portion contingent on EU approval.
Welcoming the guests, Head of the University Sports Federation of Armenia Armen Ashotyan said Armenia joined EUSA just
Jazz Pharmaceuticals PLC purchased EUSA Phanna, a specialty company with a commercial presence in the United States and the European Union for $680 million in cash, and Takeda Pharmaceutical Co.
From adaptation to Europeanisation of Polish foreign policy", Paper for EUSA Twelfth Biennial International Conference Boston, [http://euce.
It is because I am well informed in Middle Eastern affairs that I am shocked and disheartened by the EUSA motion and vote.
Towards a Theory of Differentiated Integration in the EU," EUSA Conference, February, Boston.
The futsal club are the first ever sports team at Teesside to reach the EUSA (European Universities Sports Association) championships and only the second British futsal team after Team Bath last year.
BANKING AND CREDIT NEWS-4 February 2010-Oxford Finance Corp leads USD25m loan facility to EUSA Pharma(C)1994-2010 M2 COMMUNICATIONS http://www.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, has out-licensed the exclusive worldwide rights to its preclinical stage human anti-interleukin-6 antibody to GSK for a consideration of up to $44 million, comprising an upfront fee and development milestones, plus royalties on future sales.
In 2005, Innocoll acquired the worldwide marketing rights for this product from Essex Chemis AG, an affiliated company of Schering-Plough Corporation and in August 2007 sold its marketing rights, with the exception of the US, to EUSA Pharma.